Report overview
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
This report aims to provide a comprehensive presentation of the global market for Neurological Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurological Biomarkers. This report contains market size and forecasts of Neurological Biomarkers in global, including the following market information:
Global Neurological Biomarkers Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Neurological Biomarkers Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Neurological Biomarkers companies in 2022 (%)
The global Neurological Biomarkers market was valued at US$ 7137.8 million in 2022 and is projected to reach US$ 15280 million by 2029, at a CAGR of 11.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.
We surveyed the Neurological Biomarkers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurological Biomarkers Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Neurological Biomarkers Market Segment Percentages, by Type, 2022 (%)
Proteomics
Genomics
Imaging
Bioinformatics
Others
Global Neurological Biomarkers Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Neurological Biomarkers Market Segment Percentages, by Application, 2022 (%)
Diagnostics
Drug Discovery
Personalized Medicine
Others
Global Neurological Biomarkers Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Neurological Biomarkers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurological Biomarkers revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Neurological Biomarkers revenues share in global market, 2022 (%)
Key companies Neurological Biomarkers sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Neurological Biomarkers sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neurological Biomarkers, market overview.
Chapter 2: Global Neurological Biomarkers market size in revenue and volume.
Chapter 3: Detailed analysis of Neurological Biomarkers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neurological Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Neurological Biomarkers capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
